Efficacy of postoperative adjuvant oral immunochemotherapy in patients with Dukes' B colorectal cancer

Annals of Cancer Research and Therapy

Volumn 11, Issue 1-2, 2003, Pages 201-214

  Mukai, Masaya ^a   Tajima, Takayuki ^a   Nakasaki, Hisao ^a   Sato, Shinkichi ^a   Ogoshi, Kyoji ^b   Makuuchi, Hiroyasu ^b  

^a TOKAI UNIVERSITY OISO HOSPITAL   (Japan)

^b TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

5 FU; Clinical stage; Colorectal cancer; Dukes' B cancer; Immunochemotherapy; Oral fluoropyrimidines; PSK (Krestin)

Indexed keywords

DOXIFLURIDINE; FLUOROURACIL; KRESTIN; UFT;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER IMMUNOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; SCORING SYSTEM;

EID: 5044227079     PISSN: 13446835     EISSN: None     Source Type: Journal    
DOI: 10.4993/acrt1992.11.201     Document Type: Article

References (31)

1. Carmichael, J., Popiela, T., Radstone, D., Falk, S., Borner, M., Oza, A., Skovsgaard, T., Munier, S. and Martin, C. (2002). Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 20: 3617-3627.
2. D'Agostino, R.B. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. (1998). Stat Med 17: 2265-2281.
3. Douillard, J.Y, Hoff, P.M., Skillings, J.R., Eisenberg, P., Davidson, N., Harper, P., Vincent, M.D., Lembersky, B.C., Thompson, S., Maniero, A. and Benner, S. (2002). Multi-center phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 20: 3605-3616.
4. Fujii, M. (1996). Krestin. Biotherapy 10; 315-317, (in Japanese with English abstract).
5. General Rules for Clinical and Pathological Studies on Cancer of the Colon, Rectum and Anus. Japanese Society for Cancer of the Colon and Rectum (6th edition). (1998). Kanehara & Co., Ltd., Tokyo, Japan.
6. Ho, D.W., Pazdur, R., Covington, W., Brown, N., Huo, Y.Y., Lassere, Y. and Kuritani, J. (1998). Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2′-tetrahydrofuryl)-5-fluorouracil. Clin. Cancer Res. 4: 2085-2088.
7. Japanese Classification of Gastric Carcinoma. Japanese Research Society for Gastric Cancer (1st English edition). (1995). Kanehara & Co., Ltd., Tokyo, Japan.
8. Jessup, J.M., McGinnis, L.S., Steele, G.D., Menck, H.R. and Winchester, D.P. The national cancer database report on colon cancer. (1996). Cancer 78: 918-926.
9. Jessup, J.M., Stewart, A.K. and Menck, H.R. (1998). The national cancer database report on patterns of care for adenocarcinoma of the rectum, 1985-1995. Cancer 83: 2408-2418.
10. Journal of Health and Welfare Statistics, Health and Welfare Statistics Association. (2001). Tokyo, Japan. 48: 50-54.
11. Kato, T., Ohashi, Y., Nakazato, H., Koike, A., Saji, S., Suzuki, H., Takagi, H., Nimura, Y, Hasumi, A., Baba, S., Manabe, T., Maruta, M., Mimura, K. and Yamaguchi, A. (2002). Efficacy of oral UFT as adjuvant chemotherapy to curative resection of colorectal cancer: multi-center prospective randomized trial. Arch Surg 386: 575-581.
12. Laurie, J.A., Moertel, C.G, Fleming, T.R., Wieand, H.S., Leigh, J.E., Rubin, J., McCormack, G.W., Gerstner, J.B., Krook, J.E., Malliard, J., Twito, D.I., Morton, R.F., Tschetter, L.K. and Barlow, J.F. for the North Central Cancer Treatment Group and Mayo Clinic. (1989). Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. J Clin Oncol 7: 1447-1456.
13. Lokich, J.J., Ahlgren, J.D., Gullo, J.J., Philips, J.A. and Fryer, J.G. (1989). A prospective randomized comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma: a mid-Atlantic oncology program study. J Clin Oncol 17: 425-432.
14. Mitomi, T., Tsuchiya, S., Iijima, M., Aso, K., Nishiyama, K., Amano, T., Takahashi, T., Oka, H., Murayama, N., Oya, K., Noto, T. and Ogawa, N. (1993). Randomized controlled study on adjuvant immnochemotherapy with PSK in curatively resected colorectal cancer - 5 years follow up after surgery (A final report). J Jpn Soc Cancer Ther 28: 71-83.
15. Mitomi, T., Tsuchiya, S., Iijima, N., Aso, K., Suzuki, K., Nishiyama, K., Amano, T., Takahashi, T., Murayama, N., Oka, H., Oya, K., Noto, T. and Ogawa, N. (1992). Randomized controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. Dis Colon Rectum 35: 123-130.
16. Moertel, C.G, Fleming, TR,, McDonald, J.S., Haller, D.G, Laurie, J.A., Goodman, P.J., Ungerleider, J.S., Emerson, W.A., Tormey, D.G., Glick J.H., Veeder, M.H. and Mailliard, J.A. (1990). Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Eng J Med 322: 352-358.
17. Mukai, M., Moriya, H., Himeno, S., Oida, Y., Mukoyama, S., Nishi, T., Nakasaki, H., Sato, S. and Makuuchi, H. (2001). Efficacy of oral UFT plus leucovorin therapy for colon cancer with ovarian and multiple liver metastases: report of two cases. Oncol Rep 8: 1079-1083.
18. Mukai, M., Tokunaga, N., Yasuda, S., Mukoyama, S., Itoh, I., Kameya, T., Ishikawa, K., Iwase, H., Suzuki, T., Ishida, H., Sadahiro, S. and Makukuchi, H. (2000). Long-term survival after immunochemotherapy in a patient of juvenile colon cancer with peritoneal dissemination: a case report. Oncol Rep 7: 1343-1347.
19. Multi-Institutional Registry of Large Bowel Cancer in Japan, Vol. 23, Cases treated in 1994. (2002). Japanese Society for Cancer of the Colon and Rectum, Tokyo, Japan.
20. Muto, M., Koyama, Y., Hamano, K., Yasutomi, M., Takahashi, T., Kodaira, S., Kato, T., Kameoka, S. and Ogawa, N. The Colorectal Cancer Chemotherapy Study Group of Japan, Tokyo, Japan. (2002). Evaluation of the adjuvant chemotherapy of 5-FU and MMC for curatively resected colorectal cancer in Japan by RCT. Proc. Am Soc Clin Oncol 38: No. 2271, (abstr).
21. Nakajima, T., Okabayashi, K., Nakazato, H., Iwanaga, G., Ota, K., Kito, T., Yamatsuma, Y., Furukawa, H. and Hiratsuka, M. (1989). Individual dose intensity and relative performance as indices for assessing the quality of clinical cancer chemotherapy and their effect on therapeutic results. Oncologia 22: 100-108.
22. Nakazato, H., Ito, K., Takagi, H., Saji, S., Koike, A., Baba, S., Mai, M., Ohashi, Y and Sakamoto, J. (1999). A randomized clinical trial on adjuvant immuno-chemotherapy with protein bound polysaccharide K (PSK) after curative resection of colon cancer. Proc. Am Soc Clin Oncol 35: No. 942, (abstr).
23. Ogoshi, K., Tajima, T., Mitomi, T., Makuuchi, H. and Tsuji, K. (1997). HLA-A2 antigen status predicts metastasis and response to immunotherapy in gastric cancer. Cancer Immunol Immunother 45: 53-59.
24. Rubin, D.B. and Thomas, N. (1996). Matching using estimated propensity scores: relating theory to practice. Biometrics 52: 249-264.
25. Sakamoto, J., Hamada, C., Yasutomi, M., Kodaira, S., Nakazato, H., Ohashi, Y. and Meta-analysis group in the Japanese society for cancer of the colon and rectum, Japan. (2001). Adjuvant therapy with oral fluorinated pyrimidines after curative resection for colorectal cancer: individual patient data meta-analysis of randomized trials. Proc. Am Soc Clin Oncol 37: No. 147, (abstr).
26. Sakamoto, J., Koike, A., Saji, S., Teramukai, S., Ohashi, Y. and Nakazato, H. (1992). Preoperative serum immunosuppressive acidic protein (IAP) test for the prognosis of gastric cancer: a statistical study of the threshold level and evaluation of the effect of the biological response modifier PSK. Jpn J Sur 22: 530-536.
27. Shibata, M., Nezu, T., Kanou, H., Nagata, Y., Kimura, T., Takekawa, M., Ando, K. and Fukuzawa, M. (2002). Immunomodulatory effects of low dose cis-diaminedichloroplatinum (Cisplatin) combined with UFT and PSK in patients with advanced colorectal cancer. Cancer Invest 20: 166-173.
28. Takashima, S., Kinami, Y. and Miyazaki, I. (1988). Clinical effect of postoperative adjuvant immunochemotherapy with FT-207 suppository and PSK for colorectal cancer patients. Jpn J Cancer Chemother 15: 2229-2236 (in Japanese with English abstr).
29. The Colorectal Cancer Chemotherapy Study Group of Japan. (1995). Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. Jpn J Clin Oncol 25: 91-103.
30. Toge, T. and Yamaguchi, Y. (2000). Protein-bound polysaccharide increases survival in resected gastric cancer cases stratified with a preoperative granulocyte and lymphocyte count. Oncol Rep 7: 1157-1161.
31. Torisu, M., Hayashi, Y., Ishimitsu, T., Fujimura, T., Iwasaki, K., Katano, M., Yamamoto, H., Kimura, Y, Takesue, M., Kondo, M. and Nomoto, K. (1990). Significant prolongation of disease-free period gained by oral polysaccharide K (PSK) administration after curative surgical operation of colorectal cancer. Cancer Immunol Immunother. 31: 261-268.